Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.

Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.

Luminal A breast cancers respond well to anti-hormonal therapy (HT), are associated with a generally favorable prognosis and constitute the majority of breast cancer subtypes. HT is the mainstay of treatment of these patients, accompanied by an acceptable profile of side effects, whereas the added b...

Full description

Bibliographic Details
Main Authors: Joachim Diessner, Manfred Wischnewsky, Maria Blettner, Sebastian Häusler, Wolfgang Janni, Rolf Kreienberg, Roland Stein, Tanja Stüber, Lukas Schwentner, Catharina Bartmann, Achim Wöckel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5167411?pdf=render

Internet

http://europepmc.org/articles/PMC5167411?pdf=render

Similar Items